GLOW 2 Blend
Also known as: GLOW 2
GLOW 2 is a second-generation recovery and skin research blend built around BPC-157, TB-500, and GHK-Cu, typically at adjusted ratios or concentrations. The components are unapproved research peptides.
Last updated
Mechanism of Action
Like the original GLOW formula, GLOW 2 pairs BPC-157, TB-500, and GHK-Cu to act on complementary repair pathways. BPC-157 drives VEGFR2- and nitric-oxide-mediated angiogenesis and fibroblast activity; TB-500 binds G-actin to accelerate cell migration, vascularization, and wound closure while dampening inflammation; and GHK-Cu delivers copper and upregulates collagen, elastin, and glycosaminoglycan synthesis along with antioxidant and remodeling genes. The reformulation aims to balance systemic recovery support with dermal extracellular-matrix regeneration in a single research preparation.
- Half-life
- Component-dependent: BPC-157 and GHK-Cu are short (minutes to hours), TB-500 functionally longer (days)
- Administration Routes
- subcutaneous
- Research Status
- Research Chemical
Reported Benefits
- Targets soft-tissue, tendon, and ligament repair in models
- May enhance post-injury and post-training recovery
- Supports collagen, elastin, and skin matrix synthesis via GHK-Cu
- Reported angiogenic and anti-inflammatory effects
- Reformulated ratios intended to optimize recovery and skin outcomes
- Single blend covering systemic and dermal repair targets
Potential Side Effects
- Injection-site stinging, redness, or irritation
- Possible headache, fatigue, or flushing
- Transient nausea reported anecdotally
- Unknown long-term safety as an unapproved combination product
Common Dosing
For research use only and not medical advice: research protocols mirror the original GLOW blend, commonly delivering roughly 250-500 mcg BPC-157, 250-500 mcg TB-500, and 1-2 mg GHK-Cu per subcutaneous administration a few times weekly. No validated human dosing exists.
The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.
Contraindications
- Active or prior malignancy due to angiogenic activity
- Copper sensitivity or Wilson's disease (GHK-Cu component)
- Pregnancy or breastfeeding
GLOW Blend (BPC-157, TB-500, GHK-Cu)
GLOW is a combination research blend of BPC-157, TB-500 (Thymosin Beta-4), and GHK-Cu studied for tissue repair, recovery, and skin and connective-tissue health. Each component is an unapproved research peptide.
BPC-157
A synthetic peptide fragment derived from a protein found in gastric juice, studied for its broad tissue-healing and cytoprotective effects. Popular in research for tendon, ligament, muscle, and gut repair.
TB-500
A synthetic version of the active region of Thymosin Beta-4, a naturally occurring peptide that regulates cell migration and tissue repair. Researched for recovery, flexibility, and wound healing.
GHK-Cu
A naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) widely researched for skin regeneration, collagen synthesis, and wound healing. Common in topical cosmetics.
KLOW Blend (BPC-157, TB-500, KPV, GHK-Cu)
KLOW extends the GLOW concept by adding the anti-inflammatory tripeptide KPV to BPC-157, TB-500, and GHK-Cu. It is studied for recovery, gut and tissue healing, and skin quality, and its components are unapproved research peptides.
- View
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
2015
- View
Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications
2012
- View
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response
2006
- View
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
2018